Cargando…
Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
Autoimmune Myasthenia gravis (MG) is a chronic neuromuscular disease mainly due to antibodies against the acetylcholine receptor (AChR) at the neuromuscular junction that induce invalidating muscle weaknesses. In early-onset MG, the thymus is the effector organ and is often characterized by B-cell i...
Autores principales: | Cron, Mélanie A., Maillard, Solène, Truffault, Frédérique, Gualeni, Ambra Vittoria, Gloghini, Annunziata, Fadel, Elie, Guihaire, Julien, Behin, Anthony, Berrih-Aknin, Sonia, Le Panse, Rozen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450174/ https://www.ncbi.nlm.nih.gov/pubmed/30984166 http://dx.doi.org/10.3389/fimmu.2019.00539 |
Ejemplares similares
-
Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
por: Cron, Mélanie A., et al.
Publicado: (2020) -
Regulatory B cells in myasthenia gravis are differentially affected by therapies
por: Yilmaz, Vuslat, et al.
Publicado: (2018) -
Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells
por: Verdier, Julien, et al.
Publicado: (2023) -
Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
por: Punga, Tanel, et al.
Publicado: (2014) -
Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models
por: Robinet, Marieke, et al.
Publicado: (2017)